CD44 Splice Variants as Potential Players in Alzheimer’s Disease Pathology
Authors:
- 25 May 2017
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 58 (4) , 1137-1149
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive deficits, deposition of amyloid-β (Aβ) plaques, intracellular neurofibrillary tangles, and neuronal cell death. Neuroinflammation is commonly believed to participate in AD pathogenesis. CD44 is an inflammation-related gene encoding a widely-distributed family of alternatively spliced cell surface glycoproteins that have been implicated in inflammation, metastases, and inflammation-linked neuronal injuries. Here we investigated the expression patterns of CD44S (which does not contain any alternative exon) and CD44 splice variants in postmortem hippocampal samples from AD patients and matched non-AD controls. The expression of CD44S and CD44 splice variants CD44V3, CD44V6, and CD44V10 was significantly higher in AD patients compared to non-AD controls. Immunohistochemistry of human hippocampal sections revealed that CD44S differentially localized to neuritic plaques and astrocytes, whereas CD44V3, CD44V6, and CD44V10 expression was mostly neuronal. Consistent with these findings, we found that the expression of CD44V6 and CD44V10 was induced by Aβ peptide in neuroblastoma cells and primary neurons. Furthermore, in loss of function studies we found that both CD44V10-specific siRNA and CD44V10 antibody protected neuronal cells from Aβ-induced toxicity, suggesting a causal relationship between CD44V10 and neuronal cell death. These data indicate that certain CD44 splice variants contribute to AD pathology and that CD44V10 inhibition may serve as a new neuroprotective treatment strategy for this disease.Keywords
This publication has 55 references indexed in Scilit:
- CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cellsThe FASEB Journal, 2013
- Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's diseaseMolecular Psychiatry, 2012
- CD44 Reciprocally Regulates the Differentiation of Encephalitogenic Th1/Th17 and Th2/Regulatory T Cells through Epigenetic Modulation Involving DNA Methylation of Cytokine Gene Promoters, Thereby Controlling the Development of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2011
- CD44, a therapeutic target for metastasising tumoursEuropean Journal of Cancer, 2010
- Increased CD44 Gene Expression in Lymphocytes Derived from Alzheimer Disease PatientsNeurodegenerative Diseases, 2010
- Independent component analysis of Alzheimer's DNA microarray gene expression dataMolecular Neurodegeneration, 2009
- A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approachJournal of Neurochemistry, 2007
- CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosisJournal of the Neurological Sciences, 2007
- H-CAM expression in the human nervous system: Evidence for a role in diverse glial interactionsJournal of Neurocytology, 1992
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984